Eclipsing Toxicity, Enhancing Efficacy: Clofazimine's Vanguard in the Realm of Anti-PD-1 and CTLA-4 Immunotherapy.
作者信息
Tan Ruirong, Zhao Junning, Shubhra Quazi T H
机构信息
Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu 610041, China.
National Medical Products Administration (NMPA), Beijing 100038, China.
出版信息
Research (Wash D C). 2024 Jul 9;7:0419. doi: 10.34133/research.0419. eCollection 2024.
Abstract
摘要
Zotero 插件